Here, we present a novel phenotype in an already reported heterozygous POLG2 mutation [2] with the clinical leading symptom of camptocormia, extending the phenotypic spectrum of POLG2 related mitochondrial myopathies. This evidence concerns the gene POLG2 and Camptocormia.